Type 2 diabetes monocyte microrna and mrna expression: Dyslipidemia associates with increased differentiation-related genes but not inflammatory activation

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Lucy Baldeon R ^a,b   Weigelt, Karin ^a   De Wit, Harm ^a   Ozcan, Behiye ^a   Van Oudenaren, Adri ^a   Sempértegui, Fernando ^b   Sijbrands, Eric ^a   Grosse, Laura ^c   Van Zonneveld, Anton Jan ^d   Drexhage, Hemmo A ^a,b   Leenen, Pieter J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSIDAD CENTRAL DEL ECUADOR   (Ecuador)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CD9 ANTIGEN; DUAL SPECIFICITY PHOSPHATASE 2; HEMOGLOBIN A1C; LIPID; MESSENGER RNA; MICRORNA; MICRORNA 34C 5P; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; ATF3 GENE; CD9 GENE; CELL ADHESION; CELL DIFFERENTIATION; CELL STRUCTURE; COHORT ANALYSIS; CONTROLLED STUDY; DHRS3 GENE; DISEASE ASSOCIATION; DUSP2 GENE; DYSLIPIDEMIA; ECUADOREAN; FEMALE; GENE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID BLOOD LEVEL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PTGS2 GENE; PTPN7 GENE; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; UPREGULATION; VALIDATION STUDY; BIOLOGY; COMPLICATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COHORT STUDIES; COMPUTATIONAL BIOLOGY; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MONOCYTES; RNA, MESSENGER;

EID: 84939140550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129421     Document Type: Article

References (67)

1. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281: 26602-26614. PMID: 16809344.
2. Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788. PMID: 14679172.
3. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, et al. (1998) Biological action of leptin as an angiogenic factor. Science 281: 1683-1686. PMID: 9733517.
4. Hajer GR, van Haeften TW, Visseren FL (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29: 2959-2971. doi:10.1093/eurheartj/ehn387 PMID: 18775919.
5. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factoralpha: Direct role in obesity-linked insulin resistance. Science 259: 87-91. PMID: 7678183.
6. Hotamisligil GS (2008) Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int J Obes (Lond) 32 Suppl 7: S52-S54.
7. Wajchenberg BL, Nery M, Cunha MR, Silva ME (2009) Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis. Arq Bras Endocrinol Metabol 53: 145-150. PMID: 19466206.
8. Heilbronn LK, Campbell LV (2008) Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 14: 1225-1230. PMID: 18473870.
9. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou C, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830. PMID: 14679177.
10. Dalmas E, Clement K, Guerre-Millo M (2011) Defining macrophage phenotype and function in adipose tissue. Trends Immunol 32: 307-314. doi:10.1016/j.it.2011.04.008 PMID: 21616718.
11. Swirski FK (2011) The spatial and developmental relationships in the macrophage family. Arterioscler Thromb Vasc Biol 31: 1517-1522. doi:10.1161/ATVBAHA.110.221150 PMID: 21677294.
12. Sorisky A, Molgat AS, Gagnon A (2013) Macrophage-induced adipose tissue dysfunction and the preadipocyte: Should I stay (and differentiate) or should I go? Adv Nutr 4: 67-75. doi:10.3945/an.112.003020 PMID: 23319125.
13. Simar D, Jacques A, Caillaud C (2012) Heat shock proteins induction reduces stress kinases activation, potentially improving insulin signalling in monocytes from obese subjects. Cell Stress Chaperones 17: 615-621. doi:10.1007/s12192-012-0336-4 PMID: 22457223.
14. Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, et al. (2006) The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract 73: 284-291. PMID: 16563549.
15. Gacka M, Dobosz T, Szymaniec S, Bednarska-Chabowska D, Adamiec R, Sadakierska-Chudy A (2010) Proinflammatory and atherogenic activity of monocytes in type 2 diabetes. J Diabetes Complications 24: 1-8. doi:10.1016/j.jdiacomp.2008.07.001 PMID: 18835531.
16. Dasu MR, Devaraj S, Park S, Jialal I (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33: 861-868. doi:10.2337/dc09-1799 PMID: 20067962.
17. Shiny A, Regin B, Balachandar V, Gokulakrishnan K, Mohan V, Babu S, et al. (2013) Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes. Cytokine 64: 564- 570. doi:10.1016/j.cyto.2013.08.003 PMID: 24018334.
18. Averill MM, Bornfeldt KE (2009) Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes. Curr Diab Rep 9: 18-25. PMID: 19192420.
19. Riek AE, Oh J, Bernal-Mizrachi C (2013) 1, 25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients. J Steroid Biochem Mol Biol 136: 309-312. doi:10.1016/j.jsbmb.2012.12.019 PMID: 23333932.
20. Jialal I, Kaur H, Devaraj S (2014) Toll-like receptor status in obesity and metabolic syndrome: A translational perspective. J Clin Endocrinol Metab 99: 39-48. doi:10.1210/jc.2013-3092 PMID: 24187406.
21. Padmos RC, Schloot NC, Beyan H, Ruwhof C, Staal FJ, de Ridder D, et al. (2008) Distinct monocyte gene-expression profiles in autoimmune diabetes. Diabetes 57: 2768-2773. doi:10.2337/db08-0496 PMID: 18599519.
22. van der Heul-Nieuwenhuijsen L, Padmos RC, Drexhage RC, de Wit H, Berghout A, Drexhage HA (2010) An inflammatory gene-expression fingerprint in monocytes of autoimmune thyroid disease patients. J Clin Endocrinol Metab 95: 1962-1971. doi:10.1210/jc.2009-1455 PMID: 20147583.
23. Grosse L, Carvalho LA, Wijkhuijs AJ, Bellingrath S, Ruland T, Ambreé O, et al. (2015) Clinical characteristics of inflammation-associated depression: Monocyte gene expression is age-related in major depressive disorder. Brain Behav Immun 44: 48-56. doi:10.1016/j.bbi.2014.08.004 PMID: 25150007.
24. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA (2008) Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 180: 5689-5698. PMID: 18390754.
25. Zhao JL, Rao DS, O'Connell RM, Garcia-Flores Y, Baltimore D (2013) MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice. Elife 2: E00537. doi:10.7554/eLife.00537 PMID: 23705069.
26. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104: 1604-1609. PMID: 17242365.
27. Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103: 12481-12486. PMID: 16885212.
28. Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, Baltimore D, et al. (2011) NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A 108: 9184-9189. doi:10.1073/pnas.1105398108 PMID: 21576471.
29. Huang Y, Liu Y, Li L, Su B, Yang L, Fan W, et al. (2014) Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: Implications for glomerular endothelial injury. BMC Nephrol 15: 142. doi:10.1186/1471-2369-15-142 PMID: 25182190.
30. Hulsmans M, De Keyzer D, Holvoet P (2011) MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 25: 2515-2527. doi:10.1096/fj.11-181149PMID: 21507901.
31. Hulsmans M, Van Dooren E, Mathieu C, Holvoet P (2012) Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin. PLoS One 7: E32794. doi:10.1371/journal.pone.0032794 PMID: 22393448.
32. Rebane A, Akdis CA (2013) MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol 132: 15-26. doi:10.1016/j.jaci.2013.04.011 PMID: 23726263.
33. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, et al. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208: 1189-1201doi:10.1084/jem.20101823PMID: 21555486.
34. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, et al. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619. doi:10.1016/j.immuni.2010.09.009 PMID: 20888269.
35. Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ (2011) Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev 22: 141-147. doi:10.1016/j.cytogfr.2011.05.002 PMID: 21703910.
36. Pauley KM, Stewart CM, Gauna AE, Dupre LC, Kuklani R, Chan AL, et al. (2011) Altered miR-146a expression in Sjogren's syndrome and its functional role in innate immunity. Eur J Immunol 41: 2029- 2039. doi:10.1002/eji.201040757 PMID: 21469088.
37. Xu WD, Lu MM, Pan HF, Ye DQ (2012) Association of MicroRNA-146a with autoimmune diseases. Inflammation 35: 1525-1529. doi:10.1007/s10753-012-9467-0 PMID: 22535496.
38. Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, et al. (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem 351: 197-205. doi:10.1007/s11010-011-0727-3 PMID: 21249428.
39. Corral-Fernandez NE, Salgado-Bustamante M, Martinez-Leija ME, Cortez-Espinosa N, Garcia-Hernandez MH, Reynaga-Hernández E, et al. (2013) Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 121: 347-353. doi:10.1055/s-0033-1341516 PMID: 23616185.
40. Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, et al. (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: A clinical study. Acta Diabetol 48: 61-69. doi:10.1007/s00592-010-0226-0 PMID: 20857148.
41. Diagnosis and classification of diabetes mellitus. Diabetes Care 34 Suppl 1: S62-S69. doi:10.2337/dc11-S062 PMID: 21193628.
42. Knijff EM, Breunis MN, van Geest MC, Kupka RW, Ruwhof C, de Wit H, et al. (2006) A relative resistance of T cells to dexamethasone in bipolar disorder. Bipolar Disord 8: 740-750. PMID: 17156159.
43. Lyons PA, Koukoulaki M, Hatton A, Doggett K, Woffendin HB, Chandhry AN, et al. (2007) Microarray analysis of human leucocyte subsets: The advantages of positive selection and rapid purification. BMC Genomics 8: 64. PMID: 17338817.
44. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, et al. (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'realtime' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-a Europe against cancer program. Leukemia 17: 2474-2486. PMID: 14562124.
45. Pothof J, Verkaik NS, van IW, Wiemer EA, Ta VT, van der Horst GT, et al. (2009) MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J 28: 2090-2099. doi:10.1038/emboj.2009.156 PMID: 19536137.
46. Mocharla P, Briand S, Giannotti G, Dorries C, Jakob P, Paneni F, et al. (2013) AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: Role for proangiogenic effects and alterations in type 2 diabetics. Blood 121: 226-236. doi:10.1182/blood-2012-01-407106 PMID: 23144172.
47. Tome-Carneiro J, Larrosa M, Yanez-Gascon MJ, Davalos A, Gil-Zamorano J, Gonzalvez M, et al. (2013) One-year supplementation with a grape extract containing resveratrol modulates inflammatoryrelated microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res 72: 69-82. doi:10.1016/j.phrs.2013.03.011 PMID: 23557933.
48. Carolan E, Hogan AE, Corrigan M, Gaotswe G, O'Connell J, Foley N, et al. (2014) The impact of childhood obesity on inflammation, innate immune cell frequency, and metabolic microRNA expression. J Clin Endocrinol Metab 99: E474-E478. doi:10.1210/jc.2013-3529 PMID: 24423308.
49. Unlu S, Tang S, Wang E, Martinez I, Tang D, Bianchi ME, et al. (2012) Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) in human peripheral blood mononuclear cells. PLoS One 7: E38899. doi:10.1371/journal.pone.0038899 PMID: 22745684.
50. Wu Z, Wu Y, Tian Y, Sun X, Liu J, Ren H, et al. (2013) Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells. Oncol Lett 6: 1447-1452. PMID: 24179539.
51. Zhou BR, Guo XF, Zhang JA, Xu Y, Li W, Wu D, et al. (2013) Elevated miR-34c-5p mediates dermal fibroblast senescence by ultraviolet irradiation. Int J Biol Sci 9: 743-752. doi:10.7150/ijbs.5345 PMID: 23983607.
52. Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, Rao P, et al. (2011) microRNA- 34c is a novel target to treat dementias. EMBO J 30: 4299-4308. doi:10.1038/emboj.2011.327 PMID: 21946562.
53. Hagman Z, Haflidadottir BS, Ansari M, Persson M, Bjartell A, Edsjo A, et al. (2013) The tumour suppressor miR-34c targets MET in prostate cancer cells. Br J Cancer 109: 1271-1278. doi:10.1038/bjc.2013. 449 PMID: 23922103.
54. Sergienko E, Xu J, Liu WH, Dahl R, Critton DA, Su Y, et al. (2012) Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation. ACS Chem Biol 7: 367-377. doi:10.1021/cb2004274PMID: 22070201.
55. Meng S, Cao J, Zhang X, Fan Y, Fang L, Wang C, et al. (2013) Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One 8: E68611. doi:10.1371/journal.pone.0068611 PMID: 23874686.
56. Beyan H, Drexhage RC, van der Heul Nieuwenhuijsen L, de Wit H, Padmos RC, Schloot NC, et al. (2010) Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: A study of identical twins. Diabetes 59: 1751-1755. doi:10.2337/db09-1433 PMID: 20393150.
57. Rocha-Perugini V, Gonzalez-Granado JM, Tejera E, Lopez-Martin S, Yanez-Mo M, Sanchez-Madrid F (2014) Tetraspanins CD9 and CD151 at the immune synapse support T-cell integrin signaling. Eur J Immunol 44: 1967-1975. doi:10.1002/eji.201344235 PMID: 24723389.
58. Jockers JJ, Novak N (2006) Different expression of adhesion molecules and tetraspanins of monocytes of patients with atopic eczema. Allergy 61: 1419-1422. PMID: 17073872.
59. Adams MK, Belyaeva OV, Wu L, Kedishvili NY (2014) The retinaldehyde reductase activity of DHRS3 is reciprocally activated by retinol dehydrogenase 10 to control retinoid homeostasis. J Biol Chem 289: 14868-14880. doi:10.1074/jbc.M114.552257 PMID: 24733397.
60. Kolseth IB, Agren J, Sundvold-Gjerstad V, Lyngstadaas SP, Wang JE, Dahle MK (2012) 9-cis retinoic acid inhibits inflammatory responses of adherent monocytes and increases their ability to induce classical monocyte migration. J Innate Immun 4: 176-186. doi:10.1159/000332375 PMID: 22213773.
61. Pino-Lagos K, Guo Y, Noelle RJ (2010) Retinoic acid: A key player in immunity. Biofactors 36: 430- 436. doi:10.1002/biof.117 PMID: 20803520.
62. Freire WR, Belmont MJ, Mendieta P, Silva MJ, Romero K, Saenz N, et al. (2013) RESUMEN EJECUTIVO TOMO I. Encuesta Nacional de Salud y Nutrición ENSANUT- ECU 2011-2013. Ministerio de Salud Pública/Instituto Nacional de Estadísticas y Censos Quito, Ecuador.
63. Guillen P GG (2014) Conocimientos y Prácticas del Uso de Analgésicos Antiinflamatorios No esteroidales en Adultos Mayores del Centro Gerontológico del IESS. Cuenca.: Tesis Universidad de Cuenca, Facultad de Ciencias Médicas, Escuela de Medicina, Cuenca, Ecuador.
64. Jara M, Jaramillo L MJ, Ojeda M (2011) Frecuencia de automedicación de AINES y analgésicos antipiréticos y características que los rodean, en hogares de la parroquia San Blas de la ciudad de Cuenca en el año 2011.: Universiad de Cuenca, Facultad de Ciencias Médicas, Escuela de Medicina. doi:10.1016/j.arbres.2015.03.008 PMID: 25946531.
65. Perry J (2014) GWAS and T2DM Diapedia 3104928841.
66. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Segrè AV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981-990. doi:10.1038/ng.2383 PMID: 22885922.
67. Mahajan A, Go MJ, Zhang W, Below JE, Gaulton KJ, Gaulton K, et al. (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46: 234-244. doi:10.1038/ng.2897 PMID: 24509480.